Spasticity Market

Spasticity Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Osmotica Pharmaceuticals, Revance Therapeutics, Bionorica SE and Others.

Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.

DelveInsight's " Spasticity Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some Key Highlights from the Spasticity Market Report:

· In the US, about 764,000 children and adults currently have Cerebral Palsy and around 500,000 children under age of 18 currently have Cerebral Palsy.

· In UK the prevalence of CP is 186 per 100,000 population, such that a total of 110,000 people are affected.

· Spasticity affects approximately 35% of those with stroke, more than 90% with CP, about 50% of Traumatic brain injury (TBI) patients, 40% of SCI patients, and between 37% and 78% of MS patients.

· According to DelveInsight’s analysis, Children are affected more with Spasticity as compared to adult.

· United States has the highest percentage of Prevalent diagnosed & treated patients

View Report: https://www.delveinsight.com/report-store/spasticity-market

To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market

Spasticity is the most commonly reported symptom for Multiple sclerosis, seen in 90% of patients. Most cases of spasticity can be subdivided into spinal or cerebral spasticity. Spinal spasticity results from the removal or destruction of supraspinal control and leads to increased excitability of motor neurons, whereas cerebral spasticity stems from a loss of descending inhibition.

The American Association of Neurological Surgeons estimated that spasticity affects more than 12 million people worldwide.

View Report: https://www.delveinsight.com/report-store/spasticity-market

To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market

Some of the Spasticity Companies:

• Osmotica Pharmaceuticals,

• Revance Therapeutics

• Bionorica SE

• Merz Pharmaceuticals

• GW Pharmaceuticals Ltd.

• And Many Others

Spasticity Pipeline Therapies:

• Arbaclofen ER

• DAXI

• BX-1

• And Many Others

View Report: https://www.delveinsight.com/report-store/spasticity-market

To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market

Table of Contents

1.

Report Introduction

2.

Executive Summary of Spasticity

3.

Spasticity Market Overview at a Glance

4.

Disease Background and Overview: Spasticity

5.

Case Reports of Spasticity

6.

Spasticity Patient Journey

7.

Spasticity Epidemiology and Patient Population

8.

Epidemiology of Spasticity by Countries (2018–2030)

9.

Spasticity Treatments and Medical Practices

10.

Spasticity Marketed Therapies

11.

Spasticity Emerging Therapies

12.

Spasticity Market Size

13.

7MM: Country-wise Market Analysis

14.

Spasticity Market Drivers

15.

Spasticity Market Barriers

16.

SWOT Analysis

17.

KOL Views

18.

Reimbursement and market access

19.

Report Methodology

20.

DelveInsight Capabilities

21.

Disclaimer

22.

About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.